🇺🇸 FDA
Company

Aurinia

Aurinia Pharmaceuticals

AUPH pharma USA

Quick answer

Aurinia is a pharma company (AUPH) headquartered in EDMONTON, A0, USA with 13 tracked pipeline programs.

Pipeline (13)

project

0.05% Voclosporin Ophthalmic Solution (VOS)

Dry Eye Syndrome

Phase 3 · small_molecule · completed

1 trials project

Voclosporin

Adolescent Lupus Nephritis

Phase 3 · small_molecule · terminated

2 trials project

Voclosporin

Lupus Nephritis

Phase 3 · small_molecule · completed

3 trials project

voclosporin

Psoriasis

Phase 3 · small_molecule · completed

3 trials project

voclosporin

Renal Transplantation

Phase 3 · small_molecule · terminated

1 trials project

Aritinercept

Myasthenia Gravis, Generalized

Phase 2 · small_molecule · active

1 trials project

Voclosporin

Focal Segmental Glomerulosclerosis

Phase 2 · small_molecule · terminated

1 trials project

Voclosporin

Covid19

Phase 2 · small_molecule · completed

1 trials project

Voclosporin

Kidney Diseases

Phase 2 · small_molecule · completed

1 trials project

Voclosporin High Dose

Lupus Nephritis

Phase 2 · small_molecule · completed

1 trials project

Voclosporin Ophthalmic Solution

Dry Eye

Phase 2 · small_molecule · completed

1 trials project

Simvastatin

Drug-drug Interaction

Phase 1 · small_molecule · completed

1 trials project

Voclosporin

Volunteers

Phase 1 · small_molecule · completed

1 trials

Drugs (1)

drug

voclosporin

LUPKYNIS

Patents (7)

patent

US 11622991

Protocol for treatment of lupus nephritis

Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10973871

Ophthalmic compositions

Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10472394

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10286036

Protocol for treatment of lupus nephritis

Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10265375

Ophthalmic compositions

Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9765119

Cyclosporine analogue mixtures and their use as immunomodulating agents

Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9017725

Topical drug delivery systems for ophthalmic use

Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)